| The tax expense represents the sum of tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year, calculated using tax rates enacted or substantively enacted by the reporting end date. Research and development tax credits are recognised on an accruals basis where it is probable that future economic benefits will flow to the entity. The current year credit reflects management's estimate of the expected payable credit under the Enhanced R&D Intensive Support (ERIS) regime for the year, pending finalisation of the formal claim.Reconciliation of the tax credit to the standard 25% corporation tax rate on the loss for the year: Loss before taxation £(338,498) (2025: £(419,960)); expected credit at 25% £(84,625) (2025: £(104,990)); non-deductible expenses £1,200 (2025: £2,310); unutilised losses carried forward £28,951 (2025: £36,494); permanent capital allowances in excess of depreciation £(200) (2025: £(219)); ERIS R&D credit £(25,326) (2025: £(5,234)); total credit £(80,000) (2025: £(71,639)).The credit is provisional pending finalisation of the formal claim and submission of the Additional Information Form. Trading losses brought forward from prior periods of £213,217 remain available for carry forward. |